Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Expands Indian Facility

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today announced the expansion of its Life Sciences and Chemical Analysis Center of Excellence in Bangalore as well as the opening of a Life Science development laboratory in an adjacent facility.

Together, the center and lab cover more than 8,000 square feet, making it the largest Agilent research facility in the world.

The Center of Excellence was originally founded in 2006 to serve Agilent's customers throughout India. The facility is now outfitted with the company's newest instruments, including the 6490 triple quadrupole and 6540 Q-TOF mass spectrometers, the 1290 and 1260 liquid chromatographs, 7700 Series ICP-MS, and 7000B GC triple quadrupole MS.

Agilent's core instruments, such as gas chromatographs, liquid chromatographs, mass spectrometers, electrophoresis, and genomics products also are available for evaluation.

"This is the first Agilent lab facility where development of application solutions, customer interactions, and training will happen in parallel," Parmeet Ahuja, country general manager for Agilent Technologies, India, said in a statement.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.